Issues Warning on "Safe Legal High" Products
12, 2004 - NEWSdial.com)
The Food and Drug Administration (FDA) is warning consumers not
purchase or consume products that claim to provide "safe
legal highs" or that are marketed as "street drug alternatives" by
Cytotec Solutions, Inc., of Tampa, Fla. Today's warning expands
on the February 2004 warning concerning a product called Green
Hornet, also marketed by Cytotec Solutions. Products by this
company have been promoted and sold on the Internet and in stores
as legal versions of illicit street drugs.
FDA issued a warning in February 2004, about adverse events experienced
by four teenagers after they consumed Green Hornet Liquid that
contained high levels of the over-the-counter drugs diphenhydramine
analyses of additional products, manufactured or distributed
by Cytotec Solutions Inc., has not only found the drugs, diphenhydramine
HCl and dextromethorphan, but ephedrine and the controlled substances
GBL and GHB as well. Although this firm is no longer producing
these products, they remain under investigation and FDA is working
to identify and address additional distributors of the products.
The agency is issuing this warning because consumers may still
have these products in their possession or may be able to buy
has taken numerous actions against various products that are
being manufactured, marketed, or distributed as street drug alternatives," said
Lester M. Crawford, D.V.M., Ph.D., Acting FDA Commissioner. "There
is no doubt that these products pose a potential public health
concern, and FDA is concerned that these products may be misused
or abused by individuals, especially minors and young adults."
products included in this warning, which consumers should not
use, are Trip2Night, Invigorate II, Snuffadelic, Liquid Speed,
Solar Water, Orange Butterfly, Schoomz and Green Hornet Liquid.
The labeling for these products lists a variety of herbal and
other ingredients but does not provide either the name of the
manufacturer or the presence of these drug ingredients.
considers any product that is promoted as a street drug alternative
to be an unapproved new drug and a misbranded drug marketed in
violation of the Federal Food, Drug, and Cosmetic Act. Also any
product containing undeclared active drug ingredients violates
the law. Such violations may result in enforcement action, including
seizure and injunction.
to April 2004 News Archives